Citius Pharmaceuticals Files Q1 2025 10-Q
Ticker: CTXR · Form: 10-Q · Filed: May 14, 2025 · CIK: 1506251
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financial-report
TL;DR
Citius Pharma filed its 10-Q for Q1 2025. Check financials.
AI Summary
Citius Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Nevada, is focused on pharmaceutical preparations. Its principal executive offices are located at 11 Commerce Drive, Cranford, NJ.
Why It Matters
This filing provides investors with an update on Citius Pharmaceuticals' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Citius Pharmaceuticals is subject to regulatory risks, clinical trial outcomes, and market competition, which can significantly impact its financial performance and stock value.
Key Players & Entities
- Citius Pharmaceuticals, Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- 11 Commerce Drive, First Floor, Cranford, NJ 07016 (location) — Principal executive offices
- 001-38174 (other) — Commission File Number
FAQ
What is the primary business of Citius Pharmaceuticals, Inc.?
Citius Pharmaceuticals, Inc. is primarily involved in pharmaceutical preparations, as indicated by its Standard Industrial Classification code [2834].
When is Citius Pharmaceuticals' fiscal year end?
Citius Pharmaceuticals' fiscal year ends on September 30th.
In which state was Citius Pharmaceuticals, Inc. incorporated?
Citius Pharmaceuticals, Inc. was incorporated in Nevada.
What is the filing date of this 10-Q report?
This 10-Q report was filed on May 14, 2025.
What was the previous name of Citius Pharmaceuticals, Inc.?
The company was formerly known as Trail One, Inc., with name changes recorded on March 14, 2011, and November 19, 2010.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Citius Pharmaceuticals, Inc. (CTXR).